VIR
USDVir Biotechnology Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$5.460
Максимум
$5.520
Минимум
$5.200
Объем
1.66M
Фундаментальные показатели компании
Рыночная капитализация
729.3M
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
1.44M
Биржа
NMS
Валюта
USD
52-недельный диапазон
Связанные новости
Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2025 Financial Results on November 5, 2025
Vir Biotechnology, Inc. (NASDAQ:VIR), today announced that the Company will provide a corporate update and report financial results for the third quarter ended September 30, 2025, on November 5, 2025. The Company will
Vir Biotechnology Announces First Patient Dosed in Part 3 of Phase 1 Trial of PSMA-Targeting PRO-XTEN® Dual-Masked T-Cell Engager VIR-5500 in Combination with Androgen Receptor Pathway Inhibitors for the Treatment of Metastatic Prostate Cancer
– Phase 1 clinical trial designed to assess the safety, pharmacokinetics and preliminary efficacy of VIR-5500 in combination with androgen receptor pathway inhibitors in first-line mCRPC – Clinical trial builds on
Vir Biotechnology to Present Week 48 SOLSTICE Clinical Results in Hepatitis Delta at AASLD's The Liver Meeting® 2025
– Week 48 endpoint results from the SOLSTICE Phase 2 clinical study evaluating tobevibart alone or in combination with elebsiran for chronic hepatitis delta to be presented – Vir Biotechnology to showcase progress in
Связанные акции
IKT
Inhibikase Therapeutics Inc.
INFU
InfuSystems Holdings Inc.
VEEE
Twin Vee PowerCats Co.
CDTX
Cidara Therapeutics Inc.
QRTEP
Qurate Retail Inc. 8.0% Fixed Rate Cumulative Redeemable Preferred Stock
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.